Related references
Note: Only part of the references are listed.Worldwide distribution of allelic variation at the progesterone receptor locus and the incidence of female reproductive cancers
L. Christie Rockwell et al.
AMERICAN JOURNAL OF HUMAN BIOLOGY (2012)
Progesterone receptor gene variants and risk of endometrial cancer
Tracy A. O'Mara et al.
CARCINOGENESIS (2011)
Association of progesterone receptor polymorphism with idiopathic recurrent pregnancy loss in Taiwanese Han population
Mei-Tsz Su et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2011)
Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach
Eunjung Lee et al.
CARCINOGENESIS (2010)
Genetic Variation in the Progesterone Receptor and Metabolism Pathways and Hormone Therapy in Relation to Breast Cancer Risk
Kerryn W. Reding et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Association of the Progesterone Receptor Gene With Endometrial Cancer Risk in a Chinese Population
Wang-Hong Xu et al.
CANCER (2009)
Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium
Mia M. Gaudet et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer
Brenda Diergaarde et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression
Carey K. Anders et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Could transdermal estradiol plus progesterone be a safer postmenopausal HRT? A review
Marc L'Hermite et al.
MATURITAS (2008)
Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies
Sharon E. Johnatty et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology
Timothy R. Rebbeck et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Case-control study of postmenopausal hormone replacement therapy and endometrial cancer
Brian L. Strom et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
PGR +331 A/G and increased risk of epithelial ovarian cancer
Harvey A. Risch et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk:: a Spanish case-control study
L. P. Fernandez et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Association of the progesterone receptor gene with breast cancer risk: A single-nucleotide polymorphism tagging approach
KA Pooley et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Association between polymorphisms in the progesterone receptor gene and endometriosis
SA Treloar et al.
MOLECULAR HUMAN REPRODUCTION (2005)
Practical aspects of sharing controls between case-control studies
GR Bunin et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2005)
Progestins and progesterone in hormone replacement therapy and the risk of breast cancer
C Campagnoli et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Clarifying the PROGINS allele association in ovarian and breast cancer risk: A haplotype-based analysis
CL Pearce et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Association of progesterone receptor polymorphism with recurrent abortions
A Schweikert et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2004)
Estrogen receptor genotypes and haplotypes associated with breast cancer risk
B Gold et al.
CANCER RESEARCH (2004)
Evaluating associations of haplotypes with traits
DJ Schaid
GENETIC EPIDEMIOLOGY (2004)
Evaluating bias due to population stratification in case-control association studies of admixed populations
YT Wang et al.
GENETIC EPIDEMIOLOGY (2004)
Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe
C Stahlberg et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Human progesterone receptor polymorphisms and implantation failure during in vitro fertilization
DW Cramer et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Breast cancer and hormone-replacement therapy in the Million Women Study
E Banks et al.
LANCET (2003)
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer
CI Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden
HL Olsson et al.
CANCER (2003)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Progesterone receptors - animal models and cell signaling in breast cancer - Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells
JD Graham et al.
BREAST CANCER RESEARCH (2002)
Haplotype tagging for the identification of common disease genes
GCL Johnson et al.
NATURE GENETICS (2001)
Mechanisms of disease - Estrogen and the risk of breast cancer
M Clemons et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
RK Ross et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
C Schairer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
